Question to the Department of Health and Social Care:

To ask Her Majesty's Government, in the context of the medication and error programme outlined in the Report of the Short Life Working Group on reducing medication-related harm published on 23 February, which indicators will be included in phase one of the medicines safety dashboard being developed by NHS Digital and the NHS Business Services Authority.

The purpose of the indicators is to highlight prescribing practice that may increase the risk of harm and that is associated with admission to hospital. Phase one includes a total of six indicators; five looking at higher risk prescribing that results in admission to hospital with a gastro-intestinal bleed (four indicators and one composite) and one looking at higher risk prescribing that results in admission associated with acute kidney injury.